Food additive carrageenan: Part II: A critical review of carrageenan in vivo safety studies
- PMID: 24467586
- DOI: 10.3109/10408444.2013.861798
Food additive carrageenan: Part II: A critical review of carrageenan in vivo safety studies
Abstract
Carrageenan (CGN) is a seaweed-derived high molecular weight (Mw) hydrocolloid, primarily used as a stabilizer and thickener in food. The safety of CGN regarding its use in food is reviewed. Based on experimental studies in animals, ingested CGN is excreted quantitatively in the feces. Studies have shown that CGN is not significantly degraded by low gastric pH or microflora in the gastrointestinal (GI) tract. Due to its Mw, structure and its stability when bound to protein, CGN is not significantly absorbed or metabolized. CGN also does not significantly affect the absorption of nutrients. Subchronic and chronic feeding studies in rodents indicate that CGN at doses up to 5% in the diet does not induce any toxicological effects other than soft stools or diarrhea, which are a common effect for non-digestible high molecular weight compounds. Review of several studies from numerous species indicates that food grade CGN does not produce intestinal ulceration at doses up to 5% in the diet. Effects of CGN on the immune system following parenteral administration are well known, but not relevant to food additive uses. The majority of the studies evaluating the immunotoxicity potential were conducted with CGN administered in drinking water or by oral gavage where CGN exists in a random, open structured molecular conformation, particularly the lambda form; hence, it has more exposure to the intestinal mucosa than when bound to protein in food. Based on the many animal subchronic and chronic toxicity studies, CGN has not been found to affect the immune system, as judged by lack of effects on organ histopathology, clinical chemistry, hematology, normal health, and the lack of target organ toxicities. In these studies, animals consumed CGN at orders of magnitude above levels of CGN in the human diet: ≥1000 mg/kg/d in animals compared to 18-40 mg/kg/d estimated in the human diet. Dietary CGN has been shown to lack carcinogenic, tumor promoter, genotoxic, developmental, and reproductive effects in animal studies. CGN in infant formula has been shown to be safe in infant baboons and in an epidemiology study on human infants at current use levels.
Similar articles
-
Food additive carrageenan: Part I: A critical review of carrageenan in vitro studies, potential pitfalls, and implications for human health and safety.Crit Rev Toxicol. 2014 Mar;44(3):211-43. doi: 10.3109/10408444.2013.861797. Epub 2014 Jan 24. Crit Rev Toxicol. 2014. PMID: 24456237 Review.
-
Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.Food Chem Toxicol. 2008 Mar;46 Suppl 1:S2-70. doi: 10.1016/j.fct.2008.02.008. Epub 2008 Feb 13. Food Chem Toxicol. 2008. PMID: 18328408 Review.
-
Parameters and pitfalls to consider in the conduct of food additive research, Carrageenan as a case study.Food Chem Toxicol. 2016 Jan;87:31-44. doi: 10.1016/j.fct.2015.11.014. Epub 2015 Nov 23. Food Chem Toxicol. 2016. PMID: 26615870
-
Revisiting the carrageenan controversy: do we really understand the digestive fate and safety of carrageenan in our foods?Food Funct. 2018 Mar 1;9(3):1344-1352. doi: 10.1039/c7fo01721a. Epub 2018 Feb 22. Food Funct. 2018. PMID: 29469913 Review.
-
Clarifying the confusion between poligeenan, degraded carrageenan, and carrageenan: A review of the chemistry, nomenclature, and in vivo toxicology by the oral route.Crit Rev Food Sci Nutr. 2019;59(19):3054-3073. doi: 10.1080/10408398.2018.1481822. Epub 2018 Nov 16. Crit Rev Food Sci Nutr. 2019. PMID: 29902080 Review.
Cited by 24 articles
-
Neuroprotective Potentials of Marine Algae and Their Bioactive Metabolites: Pharmacological Insights and Therapeutic Advances.Mar Drugs. 2020 Jul 1;18(7):347. doi: 10.3390/md18070347. Mar Drugs. 2020. PMID: 32630301 Free PMC article. Review.
-
Re-evaluation of carrageenan (E 407) and processed Eucheuma seaweed (E 407a) as food additives.EFSA J. 2018 Apr 26;16(4):e05238. doi: 10.2903/j.efsa.2018.5238. eCollection 2018 Apr. EFSA J. 2018. PMID: 32625873 Free PMC article.
-
Inhibitory Effects of Carrageenans on Endotoxin-Induced Inflammation.Mar Drugs. 2020 May 10;18(5):248. doi: 10.3390/md18050248. Mar Drugs. 2020. PMID: 32397584 Free PMC article.
-
Carrageenan-Free Diet Shows Improved Glucose Tolerance and Insulin Signaling in Prediabetes: A Randomized, Pilot Clinical Trial.J Diabetes Res. 2020 Apr 21;2020:8267980. doi: 10.1155/2020/8267980. eCollection 2020. J Diabetes Res. 2020. PMID: 32377523 Free PMC article.
-
Carrageenans from the Red Seaweed Sarconema filiforme Attenuate Symptoms of Diet-Induced Metabolic Syndrome in Rats.Mar Drugs. 2020 Jan 31;18(2):97. doi: 10.3390/md18020097. Mar Drugs. 2020. PMID: 32023936 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
-
Full Text Sources
-
Other Literature Sources